Final rule 2025-04978
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Source-supplied record
Document details
- Document number
- 2025-04978
- Published
- Mar 25, 2025
- Effective
- Dec 26, 2024
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 13553
Docket identifiers
- Docket No. FDA-2021-N-0862
CFR references
- Title 21, part 201
- Title 21, part 314